Literature DB >> 29744959

Time until relapse after augmentation with single-dose ketamine in treatment-resistant depression.

Rodrigo Pérez-Esparza1,2, Teresa Corona3, Ramiro Gilberto Ruiz-García1, Nelcy Oñate-Cadena1, Camilo de la Fuente-Sandoval1,4, Jesús Ramírez-Bermúdez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29744959     DOI： 10.1111/pcn.12675

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  4 in total

Review 1.  Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis.

Authors:  Ashley A Conley; Amber E Q Norwood; Thomas C Hatvany; James D Griffith; Kathryn E Barber
Journal:  Psychopharmacology (Berl)       Date:  2021-03-31       Impact factor: 4.530

2.  Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model.

Authors:  Idriss Ali Abdoulaye; Shan-Shan Wu; Enkhmurun Chibaatar; Da-Fan Yu; Kai Le; Xue-Jin Cao; Yi-Jing Guo
Journal:  Neural Plast       Date:  2021-04-23       Impact factor: 3.144

3.  Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).

Authors:  Joakim Ekstrand; Christian Fattah; Marcus Persson; Tony Cheng; Pia Nordanskog; Jonas Åkeson; Anders Tingström; Mats B Lindström; Axel Nordenskjöld; Pouya Movahed Rad
Journal:  Int J Neuropsychopharmacol       Date:  2022-05-27       Impact factor: 5.678

Review 4.  Cognitive effects of rapid-acting treatments for resistant depression: Just adverse, or contributing to clinical efficacy?

Authors:  Salvador M Guinjoan; Karl-Jürgen Bär; Joan A Camprodon
Journal:  J Psychiatr Res       Date:  2021-06-15       Impact factor: 5.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.